Equities
  • Price (EUR)149.40
  • Today's Change-2.65 / -1.74%
  • Shares traded15.00
  • 1 Year change-7.69%
  • Beta1.6770
Data delayed at least 15 minutes, as of Jul 11 2025 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America and Europe. It offers complex software product development services. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver scientific informatics and enterprise technology solutions. It offers health data analytics. It also offers a set of AI-enabled capabilities to clients in banking, capital markets and other financially regulated businesses.

  • Revenue in USD (TTM)4.86bn
  • Net income in USD411.67m
  • Incorporated2002
  • Employees61.20k
  • Location
    Epam Systems IncSUITE 202, 41 UNIVERSITY DRIVENEWTOWN 18940United StatesUSA
  • Phone+1 (267) 759-9000
  • Fax+1 (267) 759-8989
  • Websitehttps://www.epam.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
EPAM:NYQ since
announced
Transaction
value
FD Technologies PLC-First Derivative BusinessDeal completed07 Oct 202407 Oct 2024Deal completed-14.35%301.67m
Neoris USA IncDeal completed04 Sep 202404 Sep 2024Deal completed-13.03%630.00m
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.